Key Financial Data Of Group

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
2023-07-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
Key financial data of group
Business results of group
Net sales
153,995,000 JPY
229,067,000 JPY
92,397,000 JPY
Ordinary profit (loss)
-303,679,000 JPY
-775,974,000 JPY
-342,330,000 JPY
Net assets
2,834,904,000 JPY
2,752,502,000 JPY
2,735,478,000 JPY
Total assets
4,141,782,000 JPY
4,329,053,000 JPY
4,356,413,000 JPY
Basic earnings (loss) per share
-9.95
-4.51
-26.97
-12.00
-5.13
Diluted earnings per share
Equity-to-asset ratio
0.683 xbrli:pure
0.633 xbrli:pure
0.628 xbrli:pure
Net cash provided by (used in) operating activities
-435,804,000 JPY
-827,669,000 JPY
-357,958,000 JPY
Net cash provided by (used in) investing activities
-10,578,000 JPY
-29,925,000 JPY
-24,104,000 JPY
Net cash provided by (used in) financing activities
308,339,000 JPY
291,819,000 JPY
-79,946,000 JPY
Cash and cash equivalents
2,531,683,000 JPY
2,669,727,000 JPY
2,773,493,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.